Please ensure Javascript is enabled for purposes of website accessibility
Cabot Prime Plus Logo
Cabot Prime Plus

Weekly Summary January 18, 2019

Cabot Prime Week Ending January 18, 2019

Cabot Weekly Review (Video)

In this week’s stock market video, Mike Cintolo discusses the market’s continued good vibes—this was the fourth week in a row of constructive action, which Mike believes bodes well for the intermediate- to longer-term. That said, he’s still watching for the intermediate-term trend to turn up (could happen early next week) and thus is holding cash, but with the evidence turning positive, putting some money to work is advised.


Quarterly Cabot Prime Members Analyst Teleconference

Wednesday, January 23, 2019 at 2 p.m. EST. Please join us by clicking here!

Cabot Wealth Webinar — Small-Cap Stocks: Beat the Market in 2019

Wednesday, February 13 at 1:00 p.m. EST. Please join us by clicking here!

Cabot Wealth Summit

Learn More and Reserve Your Place

August 14-16, 2019 | Hawthorne Hotel | Salem, Massachusetts

Advisory Services

Cabot Growth Investor

Bi-weekly Issue January 17: Mike is optimistic but still practicing patience and following the system. Last week, he bought half-sized positions (5% of the portfolio) in Ciena (CIEN), ProShares Ultra S&P Fund (SSO) and Workday (WDAY). That still leaves us with 67% in cash—enough to withstand a bottom-building process should one occur, but also providing plenty of buying power should this nascent uptrend gather steam.

Bi-weekly Update January 9: Mike says to do a little buying. The market’s trends are still pointed down, so he still thinks going slow and stepping lightly makes sense. But much of the recent action—including the flashing of a rare blast-off signal today—hints that the worst may be behind us. In the Model Portfolio, he’s restoring Buy ratings on FIVE and TWLO (try to buy on dips), and in a slightly unusual move, he’s going to buy half-sized positions in three stocks—Ciena (CIEN), ProShares Ultra S&P 500 Fund (SSO) and Workday (WDAY), with each position being about 5% of the portfolio to start. Our cash position will now be around 67%. Please Note: Due to a variety of scheduling factors, going forward, all Cabot Growth Investor issues and regular updates will be sent THURSDAY instead of Wednesday. Thus, your next issue will be sent to you next Thursday (January 17).

Other Stocks of Interest January 4: Follow ups to stocks featured August 1, 2018 (issue 1399) to January 3, 2019 (issue 1410). Since they’re not in the Model Portfolio, you don’t see them followed on a regular basis. However, we are monitoring these stocks, and this listing gives their current momentum status.

Cabot Top Ten Trader

Movers & Shakers January 18: It’s been yet another constructive week for the market—four in a row by our count. As of mid-morning Friday, the S&P 500 is sitting on a gain of 2.6% for the week, while the Nasdaq is up 2.7%. Mike’s Buy ideas this week are: Bilibili (BILI), CyberArk (CYBR) and Incyte (INCY). There are no explicit sells today, but Mike is keeping a close eye on Tesla (TSLA), Buenaventura (BVN), Franco-Nevada (FNV) and Tableau Software (DATA).

Weekly Issue January 14: Mike is OK with extending your line a bit, doing some new buying in high-potential stocks, but he’s also still keeping a good chunk of cash on the sideline and waiting for more strength to develop (maybe after a retrenchment) before turning bullish. His Market Monitor moves to a level 5 this week. As for the list, today is another batch of good-looking stocks from a variety of sectors, albeit with a heavier emphasis on medical. Mike’s Top Pick is old favorite Dexcom (DXCM)—start small and build if the recent strength continues.

Cabot Undervalued Stocks Advisor

Special Bulletin January 17: Knight-Swift Transportation Holdings (KNX) issued new quarterly adjusted earnings guidance this morning, pleasing investors and sending the stock up 6% upon the market’s open.

Special Bulletin January 16: Comerica (CMA) and Delta Air Lines (DAL) report earnings beats.

Weekly Update January 15: Crista is adding a stock to the Growth Portfolio. CF Industries Holdings (CF – yield 2.7%), one of the world’s largest producers of nitrogen products, serving customers on six continents. The company operates nine nitrogen production complexes in Canada, the U.K. and the U.S. And there is one change to the growth and income portfolio, Schlumberger (SLB) moves from Buy to Hold.

Special Bulletin January 14: SYNNEX (SNX) is now Retired from the Buy Low Opportunities Portfolio. Crista is retiring SNX from the portfolio because it met her investment objective and the fundamental outlook is now more moderate than before.

Monthly Issue January 2: Crista is adding Apollo Global Management, LLC (APO) to the Growth & Income Portfolio today, due to the extraordinary dividend yield and the eventual capital gain opportunity. Here are today’s portfolio changes: DowDuPont (DWDP) moves from Strong Buy to Buy,Southwest Airlines (LUV) moves from Strong Buy to Hold,Voya Financial (VOYA) moves from Strong Buy to Hold and WestRock (WRK) moves from Strong Buy to Buy.

Cabot Stock of the Week

Weekly Issue January 15: Given how strongly Tim preaches the values of diversification, it seems right that the stock to recommend now is a China-centric fund that specializes in rare earth metals, which are critical to the semiconductor chips and more that will power global technology in the decades ahead. The stock, Van Eck Rare Earths/Strategic Metals (REMX), was originally recommended by Carl Delfeld, chief analyst of Cabot Emerging Markets Investor. Tim has three portfolio changes today: Deckers Brands (DECK) moves from Buy to Sell, Huazhu Group Limited (HTHT) from Hold to Buy and MiX Telematics (MIXT) from Hold to Sell.

Cabot Emerging Markets Investor

Bi-weekly Update January 17: The Emerging Markets Timer (EEM) has managed to maintain its positive stance this week as most of our positions moved forward. While this is a good sign, Carl remains somewhat cautious and awaiting a stronger signal to put more of our cash to work. Today’s portfolio change: MiX Telematics (MIXT) moves from Hold a Half to Sell.

Bi-weekly Issue January 10: In the first week of 2019, a better overall stock market, weaker U.S. dollar, bargain hunting, and hopeful signs of a temporary truce in the U.S.-China trade war have all helped push our Emerging Markets Timer back into a bullish mode. As with our prior signals, Carl is not advising you to jump in with both feet since there is still a fair amount of uncertainty out there and the iShares EM Fund (EEM) needs to demonstrate staying power and work through some resistance. Still, he’s extending our line a bit with our two new buys in today’s issue: VanEck Rare Earths/Strategic Metals (REMX) and TAL Education Group (TAL). Both are rated Buy a Half.

Cabot Dividend Investor

Weekly Update January 16: Tom writes that if the market continues to recover here, it will be in a guarded and cautious state for another year or two. Beyond that, there will be fantastic opportunities to get aggressive. But, for now, he remains cautious but not fearful. There are no rating changes today.

Monthly Issue December 19: Chloe writes that it’s time for her to move on, but Cabot Dividend Investor isn’t going anywhere. She’s excited to pursue new opportunities in the New Year, and she’ll be leaving you in great hands. Tom Hutchinson, the new Chief Analyst of Cabot Dividend Investor, introduces himself in this month’s issue, with his take on the market and an exciting new stock pick. Here are today’s portfolio changes: BB&T Corp (BBT) Hold to Sell, Broadridge Financial Solutions (BR) Hold to Sell, CME Group (CME) Buy to Hold, Dunkin’ Brands (DNKN) Hold to Sell Half, Invesco Preferred ETF (PGX) Buy to Sell Half and UnitedHealth Group (UNH) Buy to Hold. Tom’s featured stock this month is: Altria Group (MO) is the largest U.S. domestic cigarette maker and one of the largest in the world.

Cabot Marijuana Investor

Update January 4: Stocks in the marijuana sector are off to a flying start this year. Our portfolio is already up more than 7% since the close of 2018—after being up 15% last year—and one of our latest buys, Cresco Labs, is up 32% since our late December purchase. As Tim mentioned previously, his position in Cronos (CRON) was overweight and he’s been looking to sell at a higher point—and he thinks this is it. So he’ll sell half of CRON today and hold the cash, which will bring our portfolio cash level to nearly 20%.

Monthly Issue December 27: In today’s issue, there are no new buy and sell recommendations, but you’ll find updates on all the stocks, including the two stocks Tim added to the portfolio last week. And as we head toward the end of 2018, he’s very optimistic that the sector will have another great run in 2019—just when most investors least expect it!

Wall Street’s Best Investments

Daily Alert January 18: Intuitive Surgical, Inc. (ISRG) from Shortex Market Letter
Daily Alert January 17: Civeo Corporation (CVEO) from The Turnaround Letter

Top Picks Issue January 16: In this issue, Nancy recaps the big winners from last year. For our Top Picks 2019, she has a huge variety of investments for your review.

Top Picks Daily Alert January 16: AMC Networks Inc. (AMCX) from Validea Hot List Newsletter
Top Picks Daily Alert January 15: Achillian Pharmaceuticals, Inc. (ACHN) from The Cheap Investor
Top Picks Daily Alert January 14: Global X Robotics & Artificial Intelligence ETF (BOTZ) from Positive Patterns

Wall Streets Best Dividend Stocks

Daily Alert January 18: Penske Automotive Group, Inc. (PAG) from Contrarian Outlook
Daily Alert January 17: Deere & Company (DE) from
Daily Alert January 16: Bristol-Myers Squibb Company (BMY) from Canaccord Genuity Research
Daily Alert January 15: Kulicke and Soffa Industries, Inc. (KLIC) from The Prudent Speculator
Top Picks Daily Alert January 14: AT&T Inc. (T) from The Inger Letter

Top Picks 2019 Issue January 9: In this issue, Nancy recaps our big winners from last year, and has a very nice—and diversified list—of a group of stocks that promise great potential for 2019.

Ask the Experts

Cabot Growth Investor

Question: Hey, where’s my issue of Cabot Growth Investor this week?

Mike: Thanks for writing -- as we wrote in last week’s update, we’re going with a tweak to our regular schedule: From now on, all regular Growth Investor updates and issues will be sent to you on Thursday, after the close. Of course, if we have any Special Bulletins, those can still be sent any time, but plan on getting CGI material on Thursdays now. That tweak is a big help to me, as some personnel changes (Paul left us!) has me writing like a madman for a few days early in some weeks--this way I’ll have more time and a clearer head to put together the best issue possible.

Question: Do you think the recent action of NTNX or TDOC in this mini-New Year rally warrant another possible look-see?

Mike: They don’t really fit my methodology chart-wise, but they probably work their way higher if the market does. Follow-up Q: ‘Chart-wise’ meaning the depth and severity of the pullback in both NTNX and TDOC, post September, relative to, say, CIEN and TWLO? A: Yes, but also just where they are on the chart -- below their 200-day lines, still with overhead resistance, etc. Not negative on them at all, they could easily do very well. But at this point the stock are basically still in downtrends (though I would say NTNX is now more sideways and trying to turn up).

Premium Reports

Cabot’s 10 Best Stocks to Buy and Hold for 2019

Special Report

January 3: Crista has designed this portfolio of 10 stocks to compete with the S&P 500 during the coming year, with no trading, no buying and no selling whatsoever.

Cabot’s Best Safe Investments for Uncertain Times

Special Report

December 21: This report gives you some suggestions of the safest, productive places to put your money when the market gets bumpy.

Cabot’s 10 Favorite Low-Priced Stocks for 2019

Special Report

December 13: Welcome to Cabot’s 10 Favorite Low-Priced Stocks for 2019, our annual pick of some little-known stocks that, for one reason or another, have a great shot of tacking on some great gains in the short-term (and, if things go well, longer-term, too). Of course, the market environment hasn’t been following the usual script—instead of a strong November-December, the market is scuffling. That will require some patience and picking your spots on the buy side, but ideally will work to our advantage (creating more advantageous entry points), too.

A Richer Retirement

Special Report This handbook is designed to help you secure a better, longer, richer retirement for yourself by making the most of your savings both before and during retirement.

Guide to Cabot Prime

This Guide to Cabot Prime will help you make the best use of your Prime membership to create a strong personal portfolio.